Volume 27, Issue 4 (10-2024)
J Arak Uni Med Sci 2024, 27(4): 211-215 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezaie Ashtiani A, Jadidi A, Khanmohammadi Hazaveh A, Aghae pour S M. Prevalence of Neurological Symptoms in Patients with COVID-19 Hospitalized in Hospitals of Arak University of Medical Sciences. J Arak Uni Med Sci 2024; 27 (4) :211-215
URL: http://jams.arakmu.ac.ir/article-1-7082-en.html
URL: http://jams.arakmu.ac.ir/article-1-7082-en.html
1- Department of Neurology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
2- Department of Nursing, School of Nursing, Arak University of Medical Sciences, Arak, Iran ,jadidi.ali83@yahoo.com
3- Department of Nursing, School of Nursing, Arak University of Medical Sciences, Arak, Iran
2- Department of Nursing, School of Nursing, Arak University of Medical Sciences, Arak, Iran ,
3- Department of Nursing, School of Nursing, Arak University of Medical Sciences, Arak, Iran
Abstract: (335 Views)
Introduction: One of the clinical manifestations of coronavirus is neurological symptoms. However, due to the emergence of this virus, little information is available about its symptoms. Therefore, this study aimed to evaluate the prevalence of neurological symptoms in patients with coronavirus at hospitals in Arak.
Methods: In this study, all patients hospitalized with COVID-19 in two hospitals in Arak who were willing to participate were selected by census. The questionnaires consisted of two parts: demographic information and the prevalence and severity of neurological symptoms, which were completed by interviews with patients.
Results: 208 patients with a mean age of 60.5±14.1 years participated in the study. Of the 20 neurological symptoms studied, only two (tingling around the mouth and cranial nerve palsy) were absent in patients. The most common neurological symptoms in patients were headache (82.5%), fatigue (81%) and muscle pain (74.9%), respectively. Also, according to the visual scale, participants reported the highest severity for headache (average: 7.5), followed by fatigue (average: 7.03), and muscle weakness (average: 6.9).
Conclusions: The results showed that the most common neurological symptoms in patients with coronary heart disease include headache, fatigue, and muscle pain and the most severe neurological symptoms in these patients are headache, fatigue, and muscle weakness. According to the findings of this study, these results can be used to diagnose patients and follow them up.
Methods: In this study, all patients hospitalized with COVID-19 in two hospitals in Arak who were willing to participate were selected by census. The questionnaires consisted of two parts: demographic information and the prevalence and severity of neurological symptoms, which were completed by interviews with patients.
Results: 208 patients with a mean age of 60.5±14.1 years participated in the study. Of the 20 neurological symptoms studied, only two (tingling around the mouth and cranial nerve palsy) were absent in patients. The most common neurological symptoms in patients were headache (82.5%), fatigue (81%) and muscle pain (74.9%), respectively. Also, according to the visual scale, participants reported the highest severity for headache (average: 7.5), followed by fatigue (average: 7.03), and muscle weakness (average: 6.9).
Conclusions: The results showed that the most common neurological symptoms in patients with coronary heart disease include headache, fatigue, and muscle pain and the most severe neurological symptoms in these patients are headache, fatigue, and muscle weakness. According to the findings of this study, these results can be used to diagnose patients and follow them up.
References
1. Delahoy MJ, Ujamaa D, Whitaker M, O'Halloran A, Anglin O, Burns E, et al. Hospitalizations associated with COVID-19 among children and adolescents—COVID-NET, 14 states, March 1, 2020–August 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1255. pmid: 34499627 doi: 10.15585/mmwr.mm7036e2
2. Fowlkes A, Gaglani M, Groover K, Thiese MS, Tyner H, Ellingson K, et al. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B. 1.617. 2 (Delta) variant predominance—eight US locations, December 2020–August 2021. MMWR Morb Mortal Wkly Rep. 2021;70(34):1167-9. pmid: 34437521 doi: 10.15585/mmwr.mm7034e4
3. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020;323(8):709-10. pmid: 31999307 doi: 10.1001/jama.2020.1097
4. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15. pmid: 33753937 doi: 10.1038/s41591-021-01283-z
5. Swerdlow DL, Finelli L. Preparation for possible sustained transmission of 2019 novel coronavirus: lessons from previous epidemics. JAMA. 2020;322(7):509-11. pmid: 32207807 doi: 10.1001/jama.2020.1960
6. Del Rio C, Malani PN. COVID-19—new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339-40. pmid: 32108857 doi: 10.1001/jama.2020.3072
7. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang Z-J. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020;323(13):1313-4. pmid: 32058570 doi: 10.1001/jama.2020.2131
8. Islam N, Ebrahimzadeh S, Salameh J-P, Kazi S, Fabiano N, Treanor L, et al. Thoracic imaging tests for the diagnosis of COVID‐19. Cochrane Database of Systematic Reviews.
9. 2021;12(3)214-20.
10. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020;7(7):CD013665. pmid: 32633856 doi: 10.1002/14651858.CD013665
11. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol. 2020;77(6):683-90. pmid: 32275288 doi: 10.1001/jamaneurol.2020.1127
12. Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”. Ann Clin Transl Neurol. 2021;8(5):1073-85. pmid: 33755344 doi: 10.1002/acn3.51350
13. Khanizadeh AM, Ejlali M, Karimzadeh F. The effect of SARS-COV-2 viruses on the function of different organs, especially the nervous system [in Persian]. The Neuroscience Journal of Shefaye Khatam. 2020;8(3):111-21. doi: 10.29252/shefa.8.3.111
14. Flores-Silva FD, García-Grimshaw M, Valdés-Ferrer SI, Vigueras-Hernández AP, Domínguez-Moreno R, Tristán-Samaniego DP, Michel-Chávez A, González-Duarte A, Vega-Boada FA, et al. Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City. PLoS One. 2021;16(4):e0247433.
15. Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y-Q, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):33. pmid: 32296069 doi: 10.1038/s41392-020-0148-4
16. Ali ST, Kang AK, Patel TR, Clark JR, Perez-Giraldo GS, Orban ZS, et al. Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”. Ann Clin Transl Neurol. 2022;9(7):950-61. pmid: 35607826 doi: 10.1002/acn3.51570
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
